Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its antiviral oral liquids, used in the prevention and treatment of cold, under the brand name of Xiangxue. The Company also offers quick medical glue series 508, used for hemostasis, stapling, embolism, hard tissue connection and wound protection. During the year ended December 31, 2009, the Company obtained approximately 86.69% of its total revenue from the sale of antiviral oral liquids and indigowoad root granules.